过去一年中添加的文章，按日期排序

Neoadjuvant systemic therapy for inoperable differentiated thyroid cancers: Impact on tumor resectability

K Dickerson, M Milas, R Metzger, C Tomeh… - Surgery, 2024 - Elsevier
14 天前 - … Limited treatment options exist for inoperable thyroid … for papillary, follicular and
anaplastic thyroid carcinomas … Tumors had BRAF V600E (6 papillary thyroid carcinoma) or …
相关文章 所有 3 个版本
[PDF] researchgate.net

[PDF][PDF] PD-L1 Expression and Its Modulating Factors in Anaplastic Thyroid Carcinoma

S Agarwal, CK Jung, P Gaddam, M Hirokawa… - 2024 - researchgate.net
92 天前 - … papillary thyroid carcinoma has been widely studied for PD-L1 expression, there are
limited … In both, ATCs were analyzed along with other primary thyroid carcinomas. In 2021, …
相关文章

PD-L1 Expression and its modulating factors in anaplastic thyroid carcinoma: a multi-institutional study

S Agarwal, CK Jung, P Gaddam… - The American Journal …, 2024 - journals.lww.com
120 天前 - … papillary thyroid carcinoma has been widely studied for PD-L1 expression, there are
limited data … included 326 PTCs, 66 FTCs, 6 poorly differentiated thyroid carcinomas, and 9 …
被引用次数：3 相关文章 所有 6 个版本

146 NEOADJUVANT SYSTEMIC THERAPY FOR “INOPERABLE” THYROID CANCERS: SURGICAL RESECTION STRATEGIES

K Dickerson, J Niu, R Metzger, C Tomeh… - British Journal of …, 2024 - academic.oup.com
174 天前 - … Limited treatment options exist for “inoperable” thyroid … of patients receiving
TKI for papillary (PTC), follicular (FTC) and anaplastic thyroid carcinomas (ATC) during 2018-2023 …
相关文章 所有 2 个版本